BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liao LM, Zhang X, Ren YF, Sun XY, Di N, Zhou N, Pan RK, Ma SH, Zhou LX. Chromogranin A (CgA) as poor prognostic factor in patients with small cell carcinoma of the cervix: results of a retrospective study of 293 patients. PLoS One 2012;7:e33674. [PMID: 22529895 DOI: 10.1371/journal.pone.0033674] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Zhou J, Wu SG, Sun JY, Tang LY, Lin HX, Li FY, Chen QH, Jin X, He ZY. Clinicopathological features of small cell carcinoma of the uterine cervix in the surveillance, epidemiology, and end results database. Oncotarget 2017;8:40425-33. [PMID: 28415576 DOI: 10.18632/oncotarget.16390] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
2 Ku JW, Zhang DY, Song X, Li XM, Zhao XK, Lv S, Hu SJ, Cheng R, Zhou F, Wu HF, Wang LD. Characterization of tissue chromogranin A (CgA) immunostaining and clinicohistopathological changes for the 125 Chinese patients with primary small cell carcinoma of the esophagus. Diseases of the Esophagus 2017;30:1-7. [DOI: 10.1093/dote/dox041] [Reference Citation Analysis]
3 Gill CM, Orfanelli T, Yoxtheimer L, Roy-McMahon C, Suhner J, Tomita S, Kalir T, Liu Y, Houldsworth J, Kolev V. Histology-specific FGFR2 alterations and FGFR2-TACC2 fusion in mixed adenoid cystic and neuroendocrine small cell carcinoma of the uterine cervix. Gynecol Oncol Rep 2020;34:100668. [PMID: 33241100 DOI: 10.1016/j.gore.2020.100668] [Reference Citation Analysis]
4 Liu H, Zhang Y, Chang J, Liu Z, Tang N. Differential expression of neuroendocrine markers, TTF-1, p53, and Ki-67 in cervical and pulmonary small cell carcinoma. Medicine (Baltimore) 2018;97:e11604. [PMID: 30045295 DOI: 10.1097/MD.0000000000011604] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
5 Xie S, Song L, Yang F, Tang C, Yang S, He J, Pan X. Enhanced efficacy of adjuvant chemotherapy and radiotherapy in selected cases of surgically resected neuroendocrine carcinoma of the uterine cervix: A retrospective cohort study. Medicine (Baltimore) 2017;96:e6361. [PMID: 28296773 DOI: 10.1097/MD.0000000000006361] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
6 Zhou J, Sun JY, Chen SY, Li FY, Lin HX, Wu SG, He ZY. Prognostic value of lymph node ratio in patients with small-cell carcinoma of the cervix based on data from a large national registry. Onco Targets Ther 2016;9:67-73. [PMID: 26730205 DOI: 10.2147/OTT.S96206] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
7 Kagabu M, Nagasawa T, Tatsuki S, Fukagawa Y, Tomabechi H, Takatori E, Kaido Y, Shoji T, Baba T. Comparison of Postoperative Adjuvant Chemotherapy and Concurrent Chemoradiotherapy for FIGO2018 Stage IIIC1 Cervical Cancer: A Retrospective Study. Medicina (Kaunas) 2021;57:548. [PMID: 34072478 DOI: 10.3390/medicina57060548] [Reference Citation Analysis]
8 Zhang Q, Xiong Y, Ye J, Zhang L, Li L. Influence of clinicopathological characteristics and comprehensive treatment models on the prognosis of small cell carcinoma of the cervix: A systematic review and meta-analysis. PLoS One 2018;13:e0192784. [PMID: 29641578 DOI: 10.1371/journal.pone.0192784] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
9 Sağnıç S, Birge Ö, Bakır MS, Karadag C, Şimşek T. Clinicopathological Analysis of Neuroendocrine Carcinoma of the Uterine Cervix: A Single-Institution Retrospective Review of 9 Cases. Int J Surg Oncol 2021;2021:8290659. [PMID: 34567803 DOI: 10.1155/2021/8290659] [Reference Citation Analysis]
10 Zhou J, Yang HY, Wu SG, He ZY, Lin HX, Sun JY, Li Q, Guo ZW. The local treatment modalities in FIGO stage I-II small-cell carcinoma of the cervix are determined by disease stage and lymph node status. Cancer Med 2016;5:1108-15. [PMID: 26990881 DOI: 10.1002/cam4.687] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
11 Satoh T, Takei Y, Treilleux I, Devouassoux-Shisheboran M, Ledermann J, Viswanathan AN, Mahner S, Provencher DM, Mileshkin L, Åvall-Lundqvist E, Pautier P, Reed NS, Fujiwara K. Gynecologic Cancer InterGroup (GCIG) consensus review for small cell carcinoma of the cervix. Int J Gynecol Cancer 2014;24:S102-8. [PMID: 25341572 DOI: 10.1097/IGC.0000000000000262] [Cited by in Crossref: 54] [Cited by in F6Publishing: 29] [Article Influence: 7.7] [Reference Citation Analysis]
12 Chen J, Sun Y, Chen L, Zang L, Lin C, Lu Y, Lin L, Lin A, Dan H, Chen Y, He H. Prognostic factors and treatment of neuroendocrine tumors of the uterine cervix based on the FIGO 2018 staging system: a single-institution study of 172 patients. PeerJ 2021;9:e11563. [PMID: 34268005 DOI: 10.7717/peerj.11563] [Reference Citation Analysis]
13 Chen TC, Huang HJ, Wang TY, Yang LY, Chen CH, Cheng YM, Liou WH, Hsu ST, Wen KC, Ou YC, Hung YC, Lai HC, Ho CM, Chang TC. Primary surgery versus primary radiation therapy for FIGO stages I-II small cell carcinoma of the uterine cervix: A retrospective Taiwanese Gynecologic Oncology Group study. Gynecol Oncol 2015;137:468-73. [PMID: 25797082 DOI: 10.1016/j.ygyno.2015.03.015] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
14 Yin L, Li J, Wei Y, Ma D, Sun Y, Sun Y. Primary ovarian small cell carcinoma of pulmonary type with coexisting endometrial carcinoma in a breast cancer patient receiving tamoxifen: A case report and literature review. Medicine (Baltimore) 2018;97:e10900. [PMID: 29879027 DOI: 10.1097/MD.0000000000010900] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
15 Lin LM, Lin Q, Liu J, Chu KX, Huang YX, Zhang ZK, Li T, Dai YQ, Li JL. Prognostic factors and treatment comparison in small cell neuroendocrine carcinoma of the uterine cervix based on population analyses. Cancer Med 2020;9:6524-32. [PMID: 32705800 DOI: 10.1002/cam4.3326] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
16 Kim J, Kim JY, Oh EH, Yoo C, Park IJ, Yang DH, Ryoo BY, Ryu JS, Hong SM. Chromogranin A Expression in Rectal Neuroendocrine Tumors Is Associated With More Aggressive Clinical Behavior and a Poorer Prognosis. Am J Surg Pathol 2020;44:1496-505. [PMID: 32735108 DOI: 10.1097/PAS.0000000000001526] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Wang Q, Liu YH, Xie L, Hu WJ, Liu BR. Small cell carcinoma of the uterine cervix in pregnancy: A case report and review of the literature. Oncol Lett 2015;9:91-5. [PMID: 25435939 DOI: 10.3892/ol.2014.2668] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
18 Ku JW, Zhang DY, Song X, Li XM, Zhao XK, Lv S, Hu SJ, Cheng R, Zhou FY, Wu HF, Wang LD. Characterization of tissue chromogranin A (CgA) immunostaining and clinicohistopathological changes for the 125 Chinese patients with primary small cell carcinoma of the esophagus.Dis Esophagus. 2017;30:1-7. [PMID: 28575250 DOI: 10.1093/dote/dox041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
19 Zhang DY, Huang GR, Ku JW, Zhao XK, Song X, Xu RH, Han WL, Zhou FY, Wang R, Wei MX, Wang LD. Development and validation of a prognostic nomogram model for Chinese patients with primary small cell carcinoma of the esophagus. World J Clin Cases 2021; 9(30): 9011-9022 [PMID: 34786384 DOI: 10.12998/wjcc.v9.i30.9011] [Reference Citation Analysis]
20 Atienza-Amores M, Guerini-Rocco E, Soslow RA, Park KJ, Weigelt B. Small cell carcinoma of the gynecologic tract: a multifaceted spectrum of lesions. Gynecol Oncol 2014;134:410-8. [PMID: 24875120 DOI: 10.1016/j.ygyno.2014.05.017] [Cited by in Crossref: 59] [Cited by in F6Publishing: 47] [Article Influence: 7.4] [Reference Citation Analysis]
21 Yang XL, Guan WJ, Kou LN, Wang MM, Lai H, Wu DJ. A real-world, population-based study of the trends for incidence and prognosis in high-grade neuroendocrine tumor of cervix. Curr Probl Cancer 2021;:100800. [PMID: 34838343 DOI: 10.1016/j.currproblcancer.2021.100800] [Reference Citation Analysis]
22 Huang L, Liao LM, Liu AW, Wu JB, Cheng XL, Lin JX, Zheng M. Analysis of the impact of platinum-based combination chemotherapy in small cell cervical carcinoma: a multicenter retrospective study in Chinese patients. BMC Cancer 2014;14:140. [PMID: 24575810 DOI: 10.1186/1471-2407-14-140] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]